Ractigen Therapeutics is headquartered in China Jiangsu Sheng. Ractigen Therapeutics was founded in 2016. Ractigen Therapeutics has a total of 94 patents and 1 literature
Ractigen is an early-stage pharmaceutical company committed to bringing to market first-in-class therapies designed to selectively restore the expression...